Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey

Authors

R Andrew Harkins, Emory University
Nancy L Bartlett, Washington University School of Medicine in St. Louis
Amanda F Cashen, Washington University School of Medicine in St. Louis
Brad S Kahl, Washington University School of Medicine in St. Louis
Neha Mehta-Shah, Washington University School of Medicine in St. Louis
et al

Journal

Blood Advances

Publication Date

4-29-2022

Volume

6

Issue

9

First Page

2745

Last Page

2756

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2021006504

Rights and Permissions

Harkins RA, Patel SP, Lee MJ, Switchenko JM, Ansell SM, Bartlett NL, Blum KA, Cashen AF, Casulo C, Friedberg JW, Johnston PB, Kahl BS, Leonard JP, Link BK, Lossos IS, Martin P, Maurer MJ, Mehta-Shah N, Reagan PM, Westin JR, Koff JL, Flowers CR. Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey. Blood Adv. 2022 May 10;6(9):2745-2756. doi.org/10.1182/bloodadvances.2021006504 © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Harkins, R Andrew; Bartlett, Nancy L; Cashen, Amanda F; Kahl, Brad S; Mehta-Shah, Neha; and et al, "Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey." Blood Advances. 6, 9. 2745 - 2756. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11902